MarketPeel
Insider Trading Intelligence
RB

Roberto Bellini

IKT
DIRECTOR · INHIBIKASE THERAPEUTICS, INC. · CIK 0001802453
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$2.00M
COMPANIES
1
ACTIVE SINCE
Oct 2024
HOLDINGS NOW
155,000
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Roberto Bellini, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+23.42%-0.48%+23.90%+23.90%
14d1+100.00%+17.57%-2.37%+19.94%+19.94%
30d1+0.00%-10.81%+1.18%-11.99%-11.99%
60d1+100.00%+44.14%+1.63%+42.52%+42.52%
90d1+100.00%+22.52%+2.73%+19.79%+19.79%
180d1+0.00%-14.41%-9.23%-5.19%-5.19%
1y1+0.00%-28.83%+15.75%-44.58%-44.58%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IKT · 155,000 shares · as of Jun 26, 2026
0365,000730,0001,095,0001,460,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 0 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
155,000155,000Jun 26, 2026Jun 30, 2026View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
108,176108,176Jun 30, 2025Jul 2, 2025View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
116,585116,585Feb 14, 2025Feb 19, 2025View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
73,58073,580Feb 14, 2025Feb 19, 2025View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Oct 21, 2024Oct 23, 2024View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASE
1,460,000$1.37$2.00M1,460,000Oct 21, 2024Oct 23, 2024View →
Other insiders · IKT
Loading peer insiders…
About this filer
CIK 0001802453
ROLE
Director
PRIMARY
IKT
COMPANIES
1
ACTIVE SINCE
Oct 2024
MARKETPEEL · /INSIDER/0001802453DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback